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We demonstrate that the bacteriophage E Red functions efficiently recombine linear DNA or single-strand oligonucleotides (ss-oligos)
into bacteriophage E to create specific changes in the viral genome. Point mutations, deletions, and gene replacements have been created.
While recombineering with oligonucleotides, we encountered other mutations accompanying the desired point mutational change. DNA
sequence analysis suggests that these unwanted mutations are mainly frameshift deletions introduced during oligonucleotide synthesis.
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Bacteriophages are astonishingly abundant on our plant.
It has been estimated that the number of free phage particles
exceeds 1030 (Hendrix et al., 2000). In addition to existing
free, especially as components of aquatic microbial com-
munities (Wommack and Colwell, 2000), a large number of
phages are resident prophages in bacterial genomes. Casjens
(2003) estimated the presence of 230 prophages in 51
bacterial genomes whose sequence was deciphered. Some
of these prophages code for genes of major medical impor-
tance, for example, the cholera toxin carried by CTXA
prophage (Davis and Waldor, 2003). Obviously, the genetic
analysis of phage genomes is at its infancy (Campbell,
2003). Such analysis can be facilitated by a recently
developed efficient in vivo recombination system (recom-
bineering) that uses the functions Exo, Beta, and Gam of
bacteriophage E (Yu et al., 2000; Zhang et al., 1998). These
functions promote recombination of a double-strand linear
DNA into the chromosome using flanking homologies0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: court@ncifcrf.gov (D.L. Court).between the linear DNA and the chromosome. Single-strand
oligonucleotides (ss-oligos) also promote in vivo recombi-
nation in a reaction requiring only Beta protein (Ellis et al.,
2001; Zhang et al., 2003). The electroporated ss-oligo may
anneal to transiently single-strand regions of chromosomal
DNA at the replication fork, resulting in a recombinant
(Court et al., 2003; Ellis et al., 2001). We now extend
recombineering by targeting PCR generated DNA fragments
and ss-oligos to phage. The precision and ease of these
experiments open an exciting pathway for new studies. In
addition, we analyze in detail some inaccuracies arising
from recombineering with synthetic oligonucleotides.Results
Creation of novel bacteriophage genotypes. We have been
creating mutations in phage E using recombineering with a
simple protocol. Briefly, Escherichia coli harboring a de-
fective E prophage is infected with the phage to be engi-
neered. The partial prophage carries the pL operon under
control of the cI857 temperature-sensitive repressor. The
lysogen is induced to express the Red functions, the induced
cells are made competent for electroporation, and the PCR
product or oligonucleotide is introduced by electroporation.
Following electroporation, a phage lysate is made from the
A.B. Oppenheim et al. / Virology 319 (2004) 185–189186electroporation mix. Several of our constructions are de-
scribed below.
(i) We generated suppressible mutations by introducing
UAG termination codons in essential E genes O, P,Q, S,
and E. The target phage E cII68 acquired these amber
mutations at a frequency of 1–3% in a cross with 70-
nucleotide-long ss-oligos with the UAG codon at the
center. Amber mutants were easily identified as cloudy
plaques with a double-layer bacterial lawn (Campbell,
1971): the lower layer contains the restrictive host
W3110 and the top layer contains the infected SupF
suppressor host LE392. E cII68 lyses both hosts, thereby
generating a clear plaque. Amber mutants lyse only the
infected LE392 cells and form cloudy plaques because
W3110 cells in the lower layer grow to confluence.
(ii) Previous studies of E Cro function were based primarily
on the use of one missense mutant, cro27. The phage
cI857 cro27 forms clear plaques at 37jC but cannot
form plaques at either 32 or 42jC (Eisen and Ptashne,
1971). The Cro protein contains three tyrosine residues,
and we independently replaced each tyrosine codon
with UAG. Screening plaques at 42jC in a double
layer, approximately 2% of total plaques were cloudy.
On LE392, the resultant mutants grow at 32, 37, and
42jC, but on W3110 they form plaques only at 37jC.
(iii) We used an 80-nucleotide oligo to generate a 326-bp
deletion of the cII gene in E c+. This ss-oligo provides
40 bases of homology at each end of the segment to be
deleted. E c+ normally forms turbid plaques. Clear
plaque recombinants were found at a frequency of 2%.
Sequencing showed that the resulting clear mutant
phage carried a deletion exactly corresponding to the
original design. This deletion fuses the cII translation
initiation codon to the downstream O gene, creating a
phage with O at the normal cII location. (Using
recombineering, deletions as large as 5 kb have been
generated with oligos on the E. coli chromosome with
good efficiency.)
(iv) We replaced the phage E rexA and rexB genes precisely
with a bla gene conferring ampicillin resistance. The
bla gene was first amplified by PCR using primers with
5Vhomology to the flanking regions of the rexAB genes;
the PCR product was then targeted to the E chromo-
some with recombineering. A phage lysate was grown
from the electroporation mix and used to form
lysogens. AmpR lysogens were selected and the
replacement of the rexAB genes by the bla gene in
such lysogens was confirmed by PCR analysis (Yu et
al., 2000) and by the ability of the recombinant
lysogens to plate T4rII mutant phage (Benzer, 1955).
(v) Using appropriate PCR primers and the gene SOEing
technique (Horton et al., 1990), we created a linear DNA
product containing an intact copy of the wild-type E P
gene adjoining a precise deletion of the entire ren gene
but with homology beyond ren in the ninR region of thephage. The construct was targeted to an infecting Pam80
phage; P+ recombinants were selected and screened for
the ren deletion. P+ recombinants were obtained at a
frequency of 2%; 20% of these had the deletion.
Analysis of mutations arising from the use of oligonucleo-
tides in recombineering. We have demonstrated that
recombineering provides an efficient way to manipulate
the bacteriophage genome. However, we found that some-
times oligo recombination has associated unwanted muta-
tions. To understand the origin and nature of these unwanted
mutants, we designed a protocol to score for both true
recombinants and unwanted changes. Phage E cI857 carries
a temperature-sensitive mutation in repressor; thus, the
phage forms clear plaques at 37jC and turbid plaques at
30jC (Sussman and Jacob, 1962). We designed two com-
plementary oligonucleotides 82 residues long, with wild-
type repressor gene sequence that could generate wild-type
E recombinants in a cross with E cI857 (Fig. 1). These
oligos cover about 1/10 of the cI coding region and are
centered on the cI857 allele. The recombinant lysate was
diluted and plated on W3110 at either 37 or 32jC. At 37jC,
E c+ recombinants form turbid plaques. At 32jC, both
parent and recombinant should form turbid plaques. When
plaques from the recombineering cross were grown at 37jC,
most were clear, however, 4–13% were turbid as expected
of wild-type recombinants (Table 1). When the recombinant
lysate was plated at 32jC, most plaques were turbid as
expected, however, a significant proportion, 0.5–2%, was
clear. This number is 10–40 times higher than the sponta-
neous frequency of clear plaques (approximately 0.05%)
found in lysates prepared the same way but without the
addition of oligonucleotide or with the addition of an
oligonucleotide lacking homology.
To understand the source of the unwanted clear muta-
tions, we purified clear and turbid recombinants and se-
quenced their cI gene (Fig. 1). Fourteen turbid E cI+
recombinants isolated at 37jC had all been corrected for
the cI857 mutation without additional mutations. However,
all clear plaques identified at 32jC contained other muta-
tions in cI. These mutations were about equally produced by
the two oligonucleotides. Twenty-four of twenty-five se-
quenced had mutations in the region covered by the ss-
oligo. Among these 24 mutants, 22 had also converted the
cI857 allele to wild type. One of these 22 mutants was a GC
to TA transversion, the rest were deletions of one or more
bases of the cI sequence. The one change outside of the
oligo region was a GC to TA transversion that retained the
cI857 allele and possibly arose spontaneously.
To demonstrate that these mutations were not specific to
cI857 or to the oligo sequence, we repeated the experiment
using wild-type E cI+ and complementary ss-oligos from a
different region of the cI gene in a cross (Fig. 1). These
oligonucleotides carried a single silent AT to GC change. As
before, clear plaques were found in the lysate following
recombineering. We sequenced the DNA from 16 clear
Fig. 1. Distribution of mutations generated by recombineering ss-oligo. The central rectangle represents the entire cI-coding region, with the two regions
targeted for recombineering with oligonucleotides indicated by filled boxes. Sequences of the corresponding oligonucleotides are expanded and positions of the
mutations generated are indicated. A D represents a single nucleotide deletion and dashes indicate the extent of events with greater than a single nucleotide
deletion. All mutants with the exception of those marked by asterisks (*) were converted from cI857 to cI+ or carried the silent mutation. The asterisk (*)
represents those alleles in which co-conversion of the silent allele or the cI+ allele of cI857 did not occur. Missense mutations and a single addition mutation
(+A) are indicated by the nucleotide change. Note that three of the changes are located outside the region covered by the oligonucleotide used. These are
marked on the central rectangle (the mutant above the rectangle was obtained in experiments with cI857 phage and two mutations marked below were found in
experiments with cI+ phage). Individual clear plaques were purified and then PCR amplified with oligonucleotides corresponding to the ends of the cI gene, and
both strands of the PCR products were sequenced. The sequence in the upper portion of the figure represents the oligonucleotides covering the cI857 allele
(enlarged GC pair). The cI857 mutation is a G to A transition in the coding strand (Daniels et al., 1983), resulting in an alanine to threonine change at residue
67 (A67T) in the DNA binding domain. Mutations above the sequence represent those generated by transformation with the top strand (C), and those below the
sequence were generated with the bottom strand (W) as per Table 1. The lower portion of the figure indicates experiments with E cI+ in which a silent mutation
(GC pair indicated in italics) was introduced with the oligonucleotide.
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they had undergone recombineering. Nine had a single base
pair deletion, three had longer deletions, one mutant had an
added AT base pair, one showed a CG to TA transition, and
one had a GC to AT base substitution mutation located
outside the region covered by the ss-oligo. The one mutant
lacking the signature change had a CG to TA transitionTable 1
Recombineering oligonucleotides into phage E
Exp. # Host Oligo Ec+ (%) E cI- (%)
1 DY433 W 6 2
2 HME31 W 6 1.5
3 HME31 C 13 2
4 HME31 recA W 4 0.5
5 HME31 – <0.05 <0.05
5 HME31 #100 <0.05 <0.05
6 HME31 C* 3.2 0.1
The experiments presented in this table were all carried out using E cI857
ind. The Ec+ and E cI columns detail the percentage of recombinants and
mutants among total plaques scored as follows: for Ec+, 500–2000 total
plaques were scored at 37jC; for % cI, 1000–2000 total plaques were
scored at 30jC. A detailed description of the strains and methods used can be
found in Ellis et al. (2001). ss-oligos (0.05 nmol) were used in electro-
porations.W, template strand; C, coding strand (see Fig. 1, top). Oligo #100 is
a 70-base oligonucleotide containing the wild-type galK sequence used by
Ellis et al. to repair a galKam mutation. C*, gel purified oligonucleotide.outside the region covered by the ss-oligo and may have
been a spontaneous clear mutant.
The results presented above suggest that most of the
mutations were introduced during synthesis of the ss-oligos.
Based on the results and chemistry of synthesis, one would
expect that at each position of an oligonucleotide there would
be an equal chance of not incorporating the added base
(Hecker and Rill, 1998; Temsamani et al., 1995). Examina-
tion of the sequence changes among the frameshifts shows
that they cluster toward the center of the ss-oligo. The
terminal regions lack mutations, suggesting that complete
base pairing at the termini may be important for efficient
annealing to the phage DNA.
To reduce the frequency of frameshift mutations, we
further purified the ss-oligos. Purification by HPLC did
not reduce the mutation frequency (data not shown) prob-
ably because HPLC does not efficiently separate oligos of
this length, whereas PAGE-purified oligonucleotides
yielded efficient recombineering with fewer frameshifts
(Table 1). This result supports the notion that base deletions
originating during chemical synthesis of the oligonucleo-
tides are responsible for generating mutations. Single base
frameshift deletions occur rarely as spontaneous mutations
(Schaaper and Dunn, 1991). In our examples, deletion
mutations formed usually also carried the designed change
present on the ss-oligo, suggesting that the frameshifts were
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approach described here provides a simple and sensitive
assay for oligonucleotide quality. We note that recombin-
eering with unpurified synthetic oligonucleotides could also
be used to provide an efficient way to introduce random
single base deletions at specific sites in genes or regulatory
regions. Our results do not suggest that the act of recombin-
eering causes random mutagenesis.
When recombineering with the bacterial chromosome,
one of two complementary ss-oligos gives more recombi-
nants (Ellis et al., 2001; Zhang et al., 2003). This strand bias
depends upon the direction of replication through the
recombining region with the lagging strand being the more
recombinogenic. In the phage crosses, both complementary
oligos were equally efficient in promoting recombination at
E cI (Table 1). We believe this is due to the rolling circle
mode of phage DNA replication, which can roll in either
direction (Takahashi, 1975). Thus, replication forks pass
through cI in both directions and neither strand is exclu-
sively leading or lagging.
In the cross with E cI857, we observed mottled plaques at
37jC, which suggested that the E DNAwas packaged with a
heteroduplex allele in cI (Huisman and Fox, 1986). We
purified six independent mottled plaques and found that
they gave rise to a mixture of turbid and clear plaques.
Sequence analysis showed that in all cases the turbid
plaques had incorporated the wild-type allele, whereas the
clear plaques retained the original cI857 mutation, indicat-
ing that the oligonucleotide paired with the phage chromo-
some and was incorporated without mismatch correction.
These heterozygous phages are generated in recA mutant
crosses, which suggests that the ss-oligo is annealed by Beta
protein to single-strand gaps at the replication fork (Court et
al., 2003; Stahl et al., 1997).Discussion
The discovery of new phages and the identification of
prophages in pathogenic bacteria yield genes that have no
homolog in the database. With slight modifications, the
techniques we have developed for E can be readily adapted
for use with other less studied phages. We have successfully
introduced mutations onto heteroimmune E, such as
Eimm434 and Eimm21. We anticipate that recombineering
will permit rapid and complete genetic and functional
analysis of newly identified phage genomes as well as more
intricate study of well-known phages like E.Materials and methods
Creating mutations with recombineering. The strains used
for recombineering carry a defective E prophage containing
the pL operon under control of the temperature-sensitive
repressor cI857. The genotype of one commonly used strain,DY330, is W3110 DlacU169 gal490 pglD8 kcI857 D(cro-
bioA). Others are listed in Ellis et al. (2001) and Yu et al.
(2000); all are available fromD. L. Court. The strain of choice
is grown in a shaking water bath at 32jC in LB with 0.4%
maltose to mid-exponential phase, A600 0.4–0.6 (30 ml is
adequate for several recombineering reactions). The culture is
harvested by centrifugation and resuspended in 1 ml TM
(10mM Tris base, 10mM MgSO4, pH 7.4). The phage to be
engineered is added at a multiplicity of infection of 1–3
phages/cell (we assume cell density of approximately 1 
108/ml before concentration) and allowed to adsorb at room
temperature for 15min (this step would needmodification for
other phages, i.e., adsorption on ice). Meanwhile, two flasks
with 5-ml broth are prewarmed to 32 and 42jC in separate
shaking water baths. The infected culture is divided and half-
inoculated into each flask; the cultures are incubated an
additional 15 min. The 42jC heat pulse induces prophage
functions; the 32jC uninduced culture is a control. After
induction, the flasks are well chilled in an ice water bath and
the cells transferred to chilled 35-ml centrifuge tubes and
harvested by centrifugation at approximately 6500  g for 7
min. The cells are washed once with 30-ml ice-cold sterile
water; the pellet is quickly resuspended in 1-ml ice-cold
sterile water and pelleted briefly (30 s) in a refrigerated
microfuge. The pellet is resuspended in 200-Al cold sterile
water and 50–100 Al aliquots are used for electroporation
with 100–150 ng PCR product or 10–100 ng oligonucleo-
tide. We use a BioRad E. coli Gene Pulser set at 1.8 mVand
0.1-cm cuvettes. Electroporated cells are diluted into 5 ml
39jC LB medium and incubated to allow completion of the
lytic cycle. The resulting phage lysate is diluted and titered on
appropriate bacteria to obtain single plaques (for more details,
see Thomason et al., 2003).
Oligonucleotides. The oligonucleotides were purchased
from Invitrogen without additional purification. The purified
oligonuclotide was subjected to electrophoresis in a 15%
PAGE-Urea gel, excised from the gel without direct UV
irradiation and eluted using the Elutrap electro-separation
system (Schleicher and Schuell). The size-purified oligonu-
cleotide was then precipitated with isopropanol, washed with
ethanol, dried, and stored at 20jC.Acknowledgments
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